Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 18 05 2018
revised: 30 08 2018
accepted: 31 08 2018
pubmed: 7 9 2018
medline: 15 1 2019
entrez: 7 9 2018
Statut: ppublish

Résumé

Carcinogenic heterocyclic aromatic amines (HAAs) interact with some drug transporters, like the efflux pump BCRP and the organic anion transporters OAT1 and OAT3. The present study was designed to determine whether they can also target activities of the organic cation transporters (OCTs), using mainly OCT1-, OCT2- and OCT3-overexpressing HEK293 cells. Fifteen HAAs were demonstrated to differently alter OCT activities; with a cut-off of at least 50% reduction of transporter activity by 100 μM HAAs, 5/15 HAAs, including Trp-P-1 and Trp-P-2, inhibited activities of OCT1, OCT2 and OCT3, whereas 7/15 HAAs, including PhIP and MeIQx, blocked those of OCT2 and OCT3, 1/15 HAAs reduced those of OCT1 and OCT2 and 2/15 HAAs, including AαC, only that of OCT2. IC

Identifiants

pubmed: 30189235
pii: S0887-2333(18)30190-5
doi: 10.1016/j.tiv.2018.08.015
pii:
doi:

Substances chimiques

Amines 0
Heterocyclic Compounds 0
Organic Cation Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-22

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Katia Sayyed (K)

Institut de recherche en santé, environnement et travail, UMR_S 1085, 2 Avenue du Pr Léon Bernard, Rennes 35043, France; Faculty of Sciences, EDST-AZM-Center-LBA3B, Lebanese University, Rafic Hariri Campus, Lebanon.

Christophe Camillerapp (C)

Institut de recherche en santé, environnement et travail, UMR_S 1085, 2 Avenue du Pr Léon Bernard, Rennes 35043, France.

Marc Le Vée (M)

Institut de recherche en santé, environnement et travail, UMR_S 1085, 2 Avenue du Pr Léon Bernard, Rennes 35043, France.

Arnaud Bruyère (A)

Institut de recherche en santé, environnement et travail, UMR_S 1085, 2 Avenue du Pr Léon Bernard, Rennes 35043, France.

Anne T Nies (AT)

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Auerbachstrasse 112, Stuttgart 70376, Germany.

Ziad Abdel-Razzak (Z)

Faculty of Sciences, EDST-AZM-Center-LBA3B, Lebanese University, Rafic Hariri Campus, Lebanon.

Olivier Fardel (O)

Institut de recherche en santé, environnement et travail, UMR_S 1085, 2 Avenue du Pr Léon Bernard, Rennes 35043, France; Pôle Biologie, Centre Hospitalier Universitaire, 2 rue Henri Le Guilloux, Rennes 35033, France. Electronic address: olivier.fardel@univ-rennes1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH